North America Dominates Global Mass Spectrometry Market, India/China Present Opportunities
The global mass spectrometry market is witnessing robust growth, driven by increasing research and development investments in the pharmaceutical and biotechnology sectors. Valued at $5.4 billion in 2023, this market is projected to reach $7.8 billion by 2028, expanding at an impressive compound annual growth rate (CAGR) of 7.5%. Mass spectrometry plays a crucial role in drug discovery and development processes, from early-stage research to clinical trials. As pharmaceutical companies continue to invest in biopharmaceuticals and personalized medicine, the demand for mass spectrometry instruments and services is expected to surge. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=437 While premium pricing for these advanced systems remains a restraint, emerging economies like China and India present lucrative growth opportunities. The flourishing biopharmaceutical industries in these countries are fueling the demand for mass spectrometers and hybrid ...